Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iolanda Lázaro

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Atherosclerosis|October 1, 2013
Akt and ERK/Nrf2 activation by PUFA oxidation-derived aldehydes upregulates FABP4 expression in human macrophagesIolanda Lázaro, Raimon Ferré, Lluís Masana, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 25, 2011
Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excessIolanda Lázaro, Marta Díaz, Anna Cabré, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|January 3, 2025
Fatty acids and telomere lengthMarta Crous-Bou, Iolanda Lázaro, Núria Nadal-Zaragoza, et al.
Cardiovascular Diabetology|May 7, 2013
Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patientsAnna Cabré, Pilar Valdovinos, Iolanda Lázaro, et al.
Antioxidants (Basel, Switzerland)|December 8, 2020
Ellagic Acid as a Tool to Limit the Diabetes Burden: Updated EvidenceAntonio J Amor, Carmen Gómez-Guerrero, Emilio Ortega, et al.
Cardiovascular Diabetology|November 2, 2019
Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trialNatia Peradze, Olivia M Farr, Nikolaos Perakakis, et al.
Atherosclerosis|March 17, 2012
FABP4 predicts atherogenic dyslipidemia development. The PREDIMED studyAnna Cabré, Nancy Babio, Iolanda Lázaro, et al.
Nutrition Reviews|May 17, 2024
Mediterranean Diet and Mental Health in Children and Adolescents: A Systematic ReviewPatricia Camprodon-Boadas, Aitana Gil-Dominguez, Elena De la Serna, et al.
Journal of the American College of Cardiology|October 30, 2020
Circulating Omega-3 Fatty Acids and Incident Adverse Events in Patients With Acute Myocardial InfarctionIolanda Lázaro, Ferran Rueda, Germán Cediel, et al.
Journal of Lipid Research|April 19, 2008
Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetesAnna Cabré, Iolanda Lázaro, Josefa Girona, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Atherosclerosis|October 1, 2013
Akt and ERK/Nrf2 activation by PUFA oxidation-derived aldehydes upregulates FABP4 expression in human macrophagesIolanda Lázaro, Raimon Ferré, Lluís Masana, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 25, 2011
Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excessIolanda Lázaro, Marta Díaz, Anna Cabré, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|January 3, 2025
Fatty acids and telomere lengthMarta Crous-Bou, Iolanda Lázaro, Núria Nadal-Zaragoza, et al.
Cardiovascular Diabetology|May 7, 2013
Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patientsAnna Cabré, Pilar Valdovinos, Iolanda Lázaro, et al.
Antioxidants (Basel, Switzerland)|December 8, 2020
Ellagic Acid as a Tool to Limit the Diabetes Burden: Updated EvidenceAntonio J Amor, Carmen Gómez-Guerrero, Emilio Ortega, et al.
Cardiovascular Diabetology|November 2, 2019
Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trialNatia Peradze, Olivia M Farr, Nikolaos Perakakis, et al.
Atherosclerosis|March 17, 2012
FABP4 predicts atherogenic dyslipidemia development. The PREDIMED studyAnna Cabré, Nancy Babio, Iolanda Lázaro, et al.
Nutrition Reviews|May 17, 2024
Mediterranean Diet and Mental Health in Children and Adolescents: A Systematic ReviewPatricia Camprodon-Boadas, Aitana Gil-Dominguez, Elena De la Serna, et al.
Journal of the American College of Cardiology|October 30, 2020
Circulating Omega-3 Fatty Acids and Incident Adverse Events in Patients With Acute Myocardial InfarctionIolanda Lázaro, Ferran Rueda, Germán Cediel, et al.
Journal of Lipid Research|April 19, 2008
Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetesAnna Cabré, Iolanda Lázaro, Josefa Girona, et al.
Pageof 5